ZeroStack Corp. (ZSTK)
NASDAQ: ZSTK · Real-Time Price · USD
6.96
-0.04 (-0.64%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Company Description
ZeroStack Corp. engages in commercial and wholesale in the United States, Germany, Canada, and internationally.
The company distributes pharmaceutical goods and medical products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.
It also operates as an AI-powered asset management company focused on providing decentralized AI. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026.
ZeroStack Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.
ZeroStack Corp.
| Country | Canada |
| Founded | 2019 |
| IPO Date | May 11, 2021 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 75 |
| CEO | Daniel Reis-Faria |
Contact Details
Address: 40 King St W, Suite 2400 Toronto, ON M5H 3Y2 Canada | |
| Phone | 954 842 4989 |
| Website | zerostack.ai |
Stock Details
| Ticker Symbol | ZSTK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1790169 |
| CUSIP Number | 98956L101 |
| ISIN Number | CA98956L1013 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Daniel Reis-Faria | Chief Executive Officer and Director |
| Dany Vaiman | Chief Financial Officer |
| Michael Heinrich | Executive Chairman |
| Dr. Manfred Ziegler | Managing Director |
| Patrick Moloney | Head of Product Development |
| Aaron Atin | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 27, 2026 | 10-K | Annual Report |
| Jan 29, 2026 | 8-K | Current Report |
| Jan 27, 2026 | 424B5 | Filing |
| Jan 27, 2026 | FWP | Free Writing Prospectus |
| Jan 27, 2026 | 424B3 | Prospectus |
| Jan 26, 2026 | EFFECT | Notice of Effectiveness |
| Jan 8, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Jan 6, 2026 | 8-K | Current Report |
| Dec 31, 2025 | 8-K | Current Report |
| Dec 23, 2025 | 8-K | Current Report |